Fundraising Fox
Electra Therapeutics
South San Francisco, US · Delaware corporation · 46 employees on LinkedIn · 7 known investors
Find your way into Electra Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Gary Patou to introduce you to Adam Rosenthal
You →Gary · together at Electra Therapeutics →Adam
Sign up to find every way you can get introduced to Electra Therapeutics
- Your email: who you already know at Electra Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Electra Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
Founders & leadership
Board
Investors · 7
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
How we know: HBM Partners's portfolio page · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Westlake Village BioPartners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$134.2M disclosed across 1 round · 2025
▶$134.2MraisedOct 2025 · 19 investors · BiotechnologyRule 506(b)
- Beth Seidenberg, M.D.Director
- Thomas Geninatti, Ph.D.Director
- Matthew FustDirector
- Carl Gordon, Ph.D.Director
- Nancy Stagliano, Ph.D.Director
- Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
- Offering amount
- $184.1M
- Amount sold
- $134.2M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Electra Therapeutics.
In the news
Frequently asked questions
- What does Electra Therapeutics do?
- Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
- Who founded Electra Therapeutics?
- Electra Therapeutics was founded by Adam Rosenthal.
- Who are Electra Therapeutics's investors?
- Electra Therapeutics's investors include HBM Healthcare Investments, HBM Partners, OrbiMed, RA Capital, Westlake Village BioPartners, Kleiner Perkins, NVIDIA.
- How much funding has Electra Therapeutics raised?
- Electra Therapeutics has disclosed $134.2M raised across 1 round.
- Where is Electra Therapeutics headquartered?
- Electra Therapeutics is headquartered in South San Francisco, US.